In hospital, opioid-induced respiratory depression is reversed with low-dose titrated naloxone to restore safe respiration without precipitating severe withdrawal — abrupt full reversal can cause acute pain crisis, severe agitation, hypertension, tachycardia, vomiting, pulmonary edema, arrhythmia, and seizures. ISMP and pain society guidance: (1) stop further opioid (PCA, infusion, patch as feasible — for transdermal fentanyl, remove the patch and clean the skin), stimulate the patient, position to support airway, apply oxygen 8 to 10 L/min by face mask; (2) dilute 0.4 mg naloxone in 10 mL normal saline yielding 0.04 mg/mL; (3) administer 0.04 mg (1 mL) IV over 30 seconds, then reassess every 2 to 3 minutes; repeat in 0.04 to 0.1 mg increments until RR is at least 10 and the patient is arousable; (4) anticipate renarcotization because most opioids — especially fentanyl, methadone, sustained-release products — outlast the 30 to 90 minute action of naloxone; prepare for repeat dosing or a continuous naloxone infusion (typical: two thirds of the effective bolus dose per hour); (5) continuous monitoring of RR, SpO2, capnography, sedation, and BP for at least 4 to 6 hours after the last dose; (6) document and notify the prescriber. A full bolus, waiting, or mixing into the PCA are unsafe.
In-depth explanation
Dilute, give 0.04 mg increments slowly, watch for rebound, prepare an infusion if needed. Pushing 0.4 mg straight is the trap.
For study reference only. Always follow current clinical guidelines and your institution’s protocols.